Filter
918
Text search:
formulations
Featured
Recommendations
124
New Publications
263
Language
Document type
No document type
510
Guidelines
197
Studies & Reports
112
Manuals
41
Strategic & Response Plan
15
Training Material
14
Fact sheets
11
Infographics
10
Situation Updates
3
Resource Platforms
3
Brochures
1
App
1
Countries / Regions
India
57
Global
32
Kenya
29
South Africa
19
Malawi
17
Western and Central Europe
17
Ethiopia
16
Sierra Leone
12
Nigeria
11
Tanzania
11
Bangladesh
11
Africa
11
Nepal
10
Ghana
9
Uganda
9
Philippines
9
Liberia
8
Cameroon
8
Zimbabwe
8
Zambia
8
South–East Asia Region
8
Burkina Faso
7
Senegal
7
Haiti
7
Rwanda
7
Myanmar / Burma
7
Latin America and the Carribbean
7
Eastern Europe
7
Syria
6
Namibia
6
Congo, Democratic Republic of
5
Benin
5
Mali
4
Côte d’Ivoire / Ivory Coast
4
Cambodia
4
Eswatini/ Swaziland
4
Botswana
4
Guinea
3
Niger
3
Indonesia
3
Russia
3
South Sudan
2
Germany
2
Chad
2
Peru
2
Colombia
2
Madagascar
2
Lesotho
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Venezuela
2
Tajikistan
2
Georgia
2
France
2
Pakistan
1
Afghanistan
1
Thailand
1
Malaysia
1
Mozambique
1
Argentina
1
Brazil
1
North Macedonia
1
Serbia
1
Ukraine
1
Bolivia
1
Sri Lanka
1
Chile
1
Yemen
1
West and Central Africa
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Armenia
1
Congo-Brazzaville
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
300
Clinical Guidelines
166
Public Health
65
Women & Child Health
61
Key Resources
33
Pharmacy & Technologies
16
Capacity Building
15
Toolboxes
HIV
116
TB
90
Pharmacy
69
COVID-19
60
AMR
53
Mental Health
42
Rapid Response
27
NTDs
23
NCDs
21
Caregiver
18
Ebola
13
Disability
10
Conflict
10
Planetary Health
9
Refugee
7
Cholera
6
Polio
6
Zika
6
Specific Hazards
5
Global Health Education
4
Health Financing Toolbox
3
Natural Hazards
2
L’objectif général de ce cadre est de permettre à l’OMS et à ses États Membres d’assurer la participation significative des personnes vivant avec des maladies non transmissibles, des problèmes de santé mentale et neurologiques, via un processus de cocréation et de renforcement des poli
...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll
...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
Annual and medium-term budget preparation processes are the platforms through which specific plans are transformed into actual resource allocation decisions. The aim of this Process Guide is to support key stakeholders involved in these processes (such as the Cabinet, Ministries of Finance and Healt
...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
The Global Burden of Disease Study (GBD) began 30 years ago with the goal of providing timely, valid and relevant assessments of critical health outcomes. Over this period, the GBD has become progressively more granular. The latest iteration provides assessments of thousands of outcomes for diseases
...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a
...
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an
...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep
...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia
...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support
...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica
...
In recent decades, India has witnessed a rapidly exploding epidemic of diabetes.
Indeed, India today has the second largest number of people with diabetes in the
world. The International Diabetes Federation (IDF) estimates that there are 72.9 million people with diabetes in India in 2017, which is
...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
